123 related articles for article (PubMed ID: 37476924)
1. Predicting outcomes following short-term ventricular assist device implant with the MELD-XI score.
Pidborochynski T; Bozso SJ; Buchholz H; Freed DH; MacArthur R; Conway J
Artif Organs; 2023 Nov; 47(11):1752-1761. PubMed ID: 37476924
[TBL] [Abstract][Full Text] [Related]
2. End-Stage Liver Disease Models and Outcomes in Pediatric Patients Supported With Short-Term Continuous-Flow Ventricular Assist Devices.
Malik G; Pidborochynski T; Buchholz H; Freed DH; Al-Aklabi M; Bozso SJ; Choudhry S; Anand V; Holinski P; Conway J
ASAIO J; 2020 Aug; 66(8):933-938. PubMed ID: 32740355
[TBL] [Abstract][Full Text] [Related]
3. Significance of pre and post-implant MELD-XI score on survival in children undergoing VAD implantation.
Amdani S; Boyle GJ; Cantor RS; Conway J; Godown J; Kirklin JK; Koehl D; Lal AK; Law Y; Lorts A; Rosenthal DN
J Heart Lung Transplant; 2021 Dec; 40(12):1614-1624. PubMed ID: 34598872
[TBL] [Abstract][Full Text] [Related]
4. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
[TBL] [Abstract][Full Text] [Related]
5. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
[TBL] [Abstract][Full Text] [Related]
6. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation.
Grimm JC; Magruder JT; Do N; Spinner JA; Dungan SP; Kilic A; Patel N; Nelson KL; Jacobs ML; Cameron DE; Vricella LA
Ann Thorac Surg; 2016 Feb; 101(2):730-5. PubMed ID: 26347119
[TBL] [Abstract][Full Text] [Related]
7. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction.
Farr M; Mitchell J; Lippel M; Kato TS; Jin Z; Ippolito P; Dove L; Jorde UP; Takayama H; Emond J; Naka Y; Mancini D; Lefkowitch JH; Schulze PC
J Heart Lung Transplant; 2015 Jul; 34(7):873-82. PubMed ID: 25851466
[TBL] [Abstract][Full Text] [Related]
8. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
Abe S; Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
PLoS One; 2014; 9(6):e100618. PubMed ID: 24955578
[TBL] [Abstract][Full Text] [Related]
9. Child-Turcotte-Pugh versus MELD-XI identify distinct high-risk populations for heart transplantation following ventricular assist device placement.
Leven EA; Kurdi AT; Govindarajulu U; Schiano T; Pinney S; Crismale JF
Clin Transplant; 2022 May; 36(5):e14617. PubMed ID: 35191097
[TBL] [Abstract][Full Text] [Related]
10. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
Wernly B; Lichtenauer M; Vellinga N; Boerma C; Ince C; Kelm M; Jung C
Eur J Intern Med; 2018 May; 51():80-84. PubMed ID: 29572092
[TBL] [Abstract][Full Text] [Related]
11. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.
Kim MS; Kato TS; Farr M; Wu C; Givens RC; Collado E; Mancini DM; Schulze PC
J Am Coll Cardiol; 2013 Jun; 61(22):2253-2261. PubMed ID: 23563127
[TBL] [Abstract][Full Text] [Related]
12. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
[TBL] [Abstract][Full Text] [Related]
13. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
Wernly B; Lichtenauer M; Franz M; Kabisch B; Muessig J; Masyuk M; Hoppe UC; Kelm M; Jung C
PLoS One; 2017; 12(2):e0170987. PubMed ID: 28151948
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Predictors of Mortality in Short-Term Continuous-Flow Ventricular Assist Devices.
Bozso SJ; Buchholz H; Pidborochynski T; Freed DH; MacArthur RGG; Conway J
ASAIO J; 2019; 65(8):769-774. PubMed ID: 30325847
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
[TBL] [Abstract][Full Text] [Related]
16. Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices.
Yost GL; Coyle L; Bhat G; Tatooles AJ
J Artif Organs; 2016 Mar; 19(1):21-8. PubMed ID: 26187243
[TBL] [Abstract][Full Text] [Related]
17. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
Amdani S; Simpson KE; Thrush P; Shih R; Simmonds J; Knecht K; Mogul DB; Hurley K; Koehl D; Cantor R; Naftel D; Kirklin JK; Daly KP
J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1462-1473.e12. PubMed ID: 33745714
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of liver dysfunction assessed by MELD-XI scoring system in patients undergoing transcatheter aortic valve implantation.
Arai T; Yashima F; Yanagisawa R; Tanaka M; Shimizu H; Fukuda K; Watanabe Y; Naganuma T; Araki M; Tada N; Yamanaka F; Shirai S; Yamamoto M; Hayashida K;
Int J Cardiol; 2017 Feb; 228():648-653. PubMed ID: 27883976
[TBL] [Abstract][Full Text] [Related]
19. Supporting pediatric patients with short-term continuous-flow devices.
Conway J; Al-Aklabi M; Granoski D; Islam S; Ryerson L; Anand V; Guerra G; Mackie AS; Rebeyka I; Buchholz H
J Heart Lung Transplant; 2016 May; 35(5):603-9. PubMed ID: 27009672
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Models for End-Stage Liver Disease Score in Patients With Pulsatile Flow POLVAD MEV Left Ventricular Assist Device Support.
Nadziakiewicz P; Szyguła-Jurkiewicz B; Pacholewicz J; Zakliczyński M; Przybyłowski P; Krauchuk A; Łowicka M; Zembala M
Transplant Proc; 2018 Sep; 50(7):2075-2079. PubMed ID: 30177112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
